Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones.
China and India are expected to offer good opportunities an account of improvement in healthcare infrastructure. In Africa, industry is expected to drive at lower rate on account of lack of healthcare infrastructure, expensive medical services and lack of consumer awareness.Central & South America is expected to drive at stable rates on account of costly medicines coupled with minimal awareness initiatives by regional government. Global market is also expected to have legal conflicts arising on account of patents which in turn are expected to negatively impact overall industry.
This report elaborates on the current development of the Anti-cancer Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Ariad Pharmaceuticals
GlaxoSmithKline
Amgen
Hoffmann-La Roche Ltd
Novartis
Bristol-Myers Squibb
Eli Lilly
Celgene Corporation
Bayer
Pfizer
Boehringer Ingelheim GmbH
Merck
AstraZeneca
Sanofi
Teva Pharmaceuticals
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Avastin
Rituxan
Herceptin
Alimta
Application:
Hospital
Clinic
Home Care
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Anti-cancer Drug Industry Overview
-
1.1.1 Anti-cancer Drug Market Scope and Market Segments
-
1.1.2 Anti-cancer Drug Industry Characteristics
-
1.1.3 Global and China Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Anti-cancer Drug Production Value and Growth Rate (2017-2028)
-
1.2 Global Anti-cancer Drug Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Avastin
-
1.2.2 Rituxan
-
1.2.3 Herceptin
-
1.2.4 Alimta
-
1.3 Global Anti-cancer Drug Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Clinic
-
1.3.3 Home Care
-
1.4 Market Analysis by Region
-
1.4.1 North America Anti-cancer Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Anti-cancer Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Anti-cancer Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Anti-cancer Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Anti-cancer Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Anti-cancer Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Anti-cancer Drug Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Anti-cancer Drug Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Anti-cancer Drug Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Anti-cancer Drug Industry Porter's Five Forces Model Analysis
-
2.2.3 Anti-cancer Drug Industry PEST Analysis
-
2.3 Anti-cancer Drug Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Anti-cancer Drug Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Anti-cancer Drug Industry
Chapter 3 Global and China Anti-cancer Drug Market, by Manufacturer
-
3.1 Global and China Anti-cancer Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Anti-cancer Drug Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Anti-cancer Drug Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Anti-cancer Drug Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Anti-cancer Drug Market Top 3 Players
Chapter 4 Global and China Anti-cancer Drug Market, by Type (2017-2028)
-
4.1 Anti-cancer Drug Market Trend, by Type
-
4.2 Global Anti-cancer Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Anti-cancer Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Anti-cancer Drug Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Anti-cancer Drug Price Trend, by Type (2017-2028)
-
4.3 China Anti-cancer Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Anti-cancer Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Anti-cancer Drug Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Anti-cancer Drug Price Trend, by Type (2017-2028)
Chapter 5 Global and China Anti-cancer Drug Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Anti-cancer Drug Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Anti-cancer Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Anti-cancer Drug Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Anti-cancer Drug Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Anti-cancer Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Anti-cancer Drug Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Anti-cancer Drug Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Anti-cancer Drug Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Anti-cancer Drug Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Anti-cancer Drug Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Anti-cancer Drug Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Anti-cancer Drug Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Anti-cancer Drug Market Analysis
-
7.1 North America Anti-cancer Drug Market, by Type
-
7.2 North America Anti-cancer Drug Market, by Application
-
7.3 North America Anti-cancer Drug Market Analysis and Forecast, by Country
-
7.3.1 United States Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Anti-cancer Drug Market Analysis
-
8.1 Europe Anti-cancer Drug Market, by Type
-
8.2 Europe Anti-cancer Drug Market, by Application
-
8.3 Europe Anti-cancer Drug Market Analysis and Forecast, by Country
-
8.3.1 Germany Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Anti-cancer Drug Market Analysis
-
9.1 APAC Anti-cancer Drug Market, by Type
-
9.2 APAC Anti-cancer Drug Market, by Application
-
9.3 APAC Anti-cancer Drug Market Analysis and Forecast, by Country
-
9.3.1 China Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Anti-cancer Drug Market Analysis
-
10.1 Latin America, Middle East and Africa Anti-cancer Drug Market, by Type
-
10.2 Latin America, Middle East and Africa Anti-cancer Drug Market, by Application
-
10.3 Latin America, Middle East and Africa Anti-cancer Drug Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Anti-cancer Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Anti-cancer Drug Company Profiles
-
11.1 Ariad Pharmaceuticals
-
11.1.1 Ariad Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Ariad Pharmaceuticals Anti-cancer Drug Product Profiles, Application and Specification
-
11.1.3 Ariad Pharmaceuticals Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 GlaxoSmithKline
-
11.2.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 GlaxoSmithKline Anti-cancer Drug Product Profiles, Application and Specification
-
11.2.3 GlaxoSmithKline Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Amgen
-
11.3.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Amgen Anti-cancer Drug Product Profiles, Application and Specification
-
11.3.3 Amgen Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Hoffmann-La Roche Ltd
-
11.4.1 Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Hoffmann-La Roche Ltd Anti-cancer Drug Product Profiles, Application and Specification
-
11.4.3 Hoffmann-La Roche Ltd Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Novartis
-
11.5.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Novartis Anti-cancer Drug Product Profiles, Application and Specification
-
11.5.3 Novartis Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Bristol-Myers Squibb
-
11.6.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Bristol-Myers Squibb Anti-cancer Drug Product Profiles, Application and Specification
-
11.6.3 Bristol-Myers Squibb Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Eli Lilly
-
11.7.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Eli Lilly Anti-cancer Drug Product Profiles, Application and Specification
-
11.7.3 Eli Lilly Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Celgene Corporation
-
11.8.1 Celgene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Celgene Corporation Anti-cancer Drug Product Profiles, Application and Specification
-
11.8.3 Celgene Corporation Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Bayer
-
11.9.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Bayer Anti-cancer Drug Product Profiles, Application and Specification
-
11.9.3 Bayer Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Pfizer
-
11.10.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Pfizer Anti-cancer Drug Product Profiles, Application and Specification
-
11.10.3 Pfizer Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Boehringer Ingelheim GmbH
-
11.11.1 Boehringer Ingelheim GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Boehringer Ingelheim GmbH Anti-cancer Drug Product Profiles, Application and Specification
-
11.11.3 Boehringer Ingelheim GmbH Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Merck
-
11.12.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Merck Anti-cancer Drug Product Profiles, Application and Specification
-
11.12.3 Merck Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 AstraZeneca
-
11.13.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 AstraZeneca Anti-cancer Drug Product Profiles, Application and Specification
-
11.13.3 AstraZeneca Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Sanofi
-
11.14.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Sanofi Anti-cancer Drug Product Profiles, Application and Specification
-
11.14.3 Sanofi Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 Teva Pharmaceuticals
-
11.15.1 Teva Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 Teva Pharmaceuticals Anti-cancer Drug Product Profiles, Application and Specification
-
11.15.3 Teva Pharmaceuticals Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Anti-cancer Drug Industry Investment Prospect and Risk Assessment
-
12.1 Anti-cancer Drug Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Anti-cancer Drug Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Global Anti-cancer Drug Production Value and Growth Rate (2017-2028)
-
Figure China Anti-cancer Drug Production Value and Growth Rate (2017-2028)
-
Figure Global Anti-cancer Drug Market Size and Growth Rate of Avastin (2017-2028)
-
Figure Global Anti-cancer Drug Market Size and Growth Rate of Rituxan (2017-2028)
-
Figure Global Anti-cancer Drug Market Size and Growth Rate of Herceptin (2017-2028)
-
Figure Global Anti-cancer Drug Market Size and Growth Rate of Alimta (2017-2028)
-
Figure Global Anti-cancer Drug Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Anti-cancer Drug Market Size and Growth Rate of Clinic (2017-2028)
-
Figure Global Anti-cancer Drug Market Size and Growth Rate of Home Care (2017-2028)
-
Figure North America Anti-cancer Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Anti-cancer Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Anti-cancer Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-cancer Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Anti-cancer Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Anti-cancer Drug Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Anti-cancer Drug Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Anti-cancer Drug Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Anti-cancer Drug Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Anti-cancer Drug Market Share, by Manufacturer in 2021
-
Figure Global and China Anti-cancer Drug Market Share, by Manufacturer in 2022
-
Table Global Anti-cancer Drug Sales Volume, by Type (2017-2028)
-
Table Global Anti-cancer Drug Sales Volume Share, by Type (2017-2028)
-
Figure Global Anti-cancer Drug Sales Volume Share, by Type (2017-2028)
-
Table Global Anti-cancer Drug Sales Value, by Type (2017-2028)
-
Table Global Anti-cancer Drug Sales Value Share, by Type (2017-2028)
-
Figure Global Anti-cancer Drug Price Trend, by Type (2017-2028)
-
Table China Anti-cancer Drug Sales Volume, by Type (2017-2028)
-
Table China Anti-cancer Drug Sales Volume Share, by Type (2017-2028)
-
Figure China Anti-cancer Drug Sales Volume Share, by Type (2017-2028)
-
Table China Anti-cancer Drug Sales Value, by Type (2017-2028)
-
Table China Anti-cancer Drug Sales Value Share, by Type (2017-2028)
-
Figure China Anti-cancer Drug Price Trend, by Type (2017-2028)
-
Table Global Anti-cancer Drug Sales Volume, by Application (2017-2028)
-
Table Global Anti-cancer Drug Sales Volume Share, by Application (2017-2028)
-
Figure Global Anti-cancer Drug Sales Volume Share, by Application (2017-2028)
-
Table Global Anti-cancer Drug Sales Value, by Application (2017-2028)
-
Table Global Anti-cancer Drug Sales Value Share, by Application (2017-2028)
-
Figure Global Anti-cancer Drug Sales Value Share, by Application (2017-2028)
-
Table China Anti-cancer Drug Sales Volume, by Application (2017-2028)
-
Table China Anti-cancer Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Anti-cancer Drug Sales Volume Share, by Application (2017-2028)
-
Table China Anti-cancer Drug Sales Value, by Application (2017-2028)
-
Table China Anti-cancer Drug Sales Value Share, by Application (2017-2028)
-
Figure China Anti-cancer Drug Sales Value Share, by Application (2017-2028)
-
Figure China Anti-cancer Drug Production, Import, Consumption and Export (2017-2022)
-
Figure North America Anti-cancer Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Anti-cancer Drug Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Anti-cancer Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Anti-cancer Drug Production, Import, Consumption and Export (2017-2022)
-
Table North America Anti-cancer Drug Sales Volume, by Type (2017-2028)
-
Table North America Anti-cancer Drug Sales Volume Share, by Type (2017-2028)
-
Figure North America Anti-cancer Drug Sales Volume Share, by Type (2017-2028)
-
Table North America Anti-cancer Drug Sales Volume, by Application (2017-2028)
-
Table North America Anti-cancer Drug Sales Volume Share, by Application (2017-2028)
-
Figure North America Anti-cancer Drug Sales Volume Share, by Application (2017-2028)
-
Figure United States Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure United States Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure Canada Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Table Europe Anti-cancer Drug Sales Volume, by Type (2017-2028)
-
Table Europe Anti-cancer Drug Sales Volume Share, by Type (2017-2028)
-
Figure Europe Anti-cancer Drug Sales Volume Share, by Type (2017-2028)
-
Table Europe Anti-cancer Drug Sales Volume, by Application (2017-2028)
-
Table Europe Anti-cancer Drug Sales Volume Share, by Application (2017-2028)
-
Figure Europe Anti-cancer Drug Sales Volume Share, by Application (2017-2028)
-
Figure Germany Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure UK Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure UK Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure France Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure France Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure Italy Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure Spain Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure Poland Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure Russia Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Table APAC Anti-cancer Drug Sales Volume, by Type (2017-2028)
-
Table APAC Anti-cancer Drug Sales Volume Share, by Type (2017-2028)
-
Figure APAC Anti-cancer Drug Sales Volume Share, by Type (2017-2028)
-
Table APAC Anti-cancer Drug Sales Volume, by Application (2017-2028)
-
Table APAC Anti-cancer Drug Sales Volume Share, by Application (2017-2028)
-
Figure APAC Anti-cancer Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure Japan Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure India Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure India Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Anti-cancer Drug Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Anti-cancer Drug Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-cancer Drug Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Anti-cancer Drug Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Anti-cancer Drug Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-cancer Drug Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Anti-cancer Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Anti-cancer Drug Sales Value and Growth Rate (2017-2028)
-
Table Ariad Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ariad Pharmaceuticals Product Profiles, Application and Specification
-
Table Ariad Pharmaceuticals Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GlaxoSmithKline Product Profiles, Application and Specification
-
Table GlaxoSmithKline Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Hoffmann-La Roche Ltd Product Profiles, Application and Specification
-
Table Hoffmann-La Roche Ltd Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly Product Profiles, Application and Specification
-
Table Eli Lilly Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Celgene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Celgene Corporation Product Profiles, Application and Specification
-
Table Celgene Corporation Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bayer Product Profiles, Application and Specification
-
Table Bayer Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Boehringer Ingelheim GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Boehringer Ingelheim GmbH Product Profiles, Application and Specification
-
Table Boehringer Ingelheim GmbH Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Product Profiles, Application and Specification
-
Table Merck Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca Product Profiles, Application and Specification
-
Table AstraZeneca Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Teva Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teva Pharmaceuticals Product Profiles, Application and Specification
-
Table Teva Pharmaceuticals Anti-cancer Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
